Literature DB >> 19597998

The contribution of direct TLR signaling to T cell responses.

Adeeb H Rahman1, Devon K Taylor, Laurence A Turka.   

Abstract

It is well established that Toll-like receptors (TLRs) play a critical role in the generation of innate immune responses and thereby also play an important, indirect role in the initiation of subsequent adaptive T cell responses. However, T cells also express certain TLRs, and we have focused on the physiological importance of direct TLR signaling in T cells. TLRs can function as co-stimulatory receptors that complement TCR-induced signals to enhance effector T cell proliferation, survival and cytokine production. We also found that TLR signaling pathways in T cells are required for the effective clonal expansion of antigen-specific T cells during infection in vivo. Thus, the importance of TLRs in T cell-mediated immunity reflects both T cell-extrinsic and T cell-intrinsic components, which warrants a reconsideration of the dogma that restricts germ-line encoded pattern recognition to cells of the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597998      PMCID: PMC4486050          DOI: 10.1007/s12026-009-8113-x

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  55 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii.

Authors:  Laurie A Minns; Laurence C Menard; David M Foureau; Sylvie Darche; Catherine Ronet; Daniel W Mielcarz; Dominique Buzoni-Gatel; Lloyd H Kasper
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

Review 3.  Toll-like receptors: linking innate and adaptive immunity.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

4.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

Authors:  I Gramaglia; A D Weinberg; M Lemon; M Croft
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

5.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation.

Authors:  Anne Cottalorda; Claire Verschelde; Antoine Marçais; Martine Tomkowiak; Philippe Musette; Satoshi Uematsu; Shizuo Akira; Jacqueline Marvel; Nathalie Bonnefoy-Berard
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

7.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

8.  Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

Authors:  Guangyong Peng; Zhong Guo; Yukiko Kiniwa; Kui Shin Voo; Weiyi Peng; Tihui Fu; Daniel Y Wang; Yanchun Li; Helen Y Wang; Rong-Fu Wang
Journal:  Science       Date:  2005-08-26       Impact factor: 47.728

9.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

10.  Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.

Authors:  Gersende Caron; Dorothée Duluc; Isabelle Frémaux; Pascale Jeannin; Catherine David; Hugues Gascan; Yves Delneste
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

View more
  60 in total

1.  Human labour is associated with altered regulatory T cell function and maternal immune activation.

Authors:  N M Shah; L F Edey; N Imami; M R Johnson
Journal:  Clin Exp Immunol       Date:  2019-11-03       Impact factor: 4.330

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 3.  Modulation of immune responses through direct activation of Toll-like receptors to T cells.

Authors:  G Liu; L Zhang; Y Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-29       Impact factor: 4.330

4.  Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.

Authors:  Ahmad Faisal Karim; Scott M Reba; Qing Li; W Henry Boom; Roxana E Rojas
Journal:  Eur J Immunol       Date:  2017-07-18       Impact factor: 5.532

5.  Lactobacillus gasseri OLL2809 and its RNA suppress proliferation of CD4(+) T cells through a MyD88-dependent signalling pathway.

Authors:  Ayako Yoshida; Kiyoshi Yamada; Yasumasa Yamazaki; Toshihiro Sashihara; Shuuji Ikegami; Makoto Shimizu; Mamoru Totsuka
Journal:  Immunology       Date:  2011-06-01       Impact factor: 7.397

6.  Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2.

Authors:  Wenhai Liu; Antoine Menoret; Anthony T Vella
Journal:  Cell Mol Immunol       Date:  2015-07-20       Impact factor: 11.530

Review 7.  Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.

Authors:  Ting-Ting Li; Shuji Ogino; Zhi Rong Qian
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

8.  MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection.

Authors:  Sang-Uk Seo; Hyung-Joon Kwon; Joo-Hye Song; Young-Ho Byun; Baik Lin Seong; Taro Kawai; Shizuo Akira; Mi-Na Kweon
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

Review 9.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

10.  Antigen-free adjuvant assists late effector CD4 T cells to transit to memory in lymphopenic hosts.

Authors:  F Betul Guloglu; Jason S Ellis; Xiaoxiao Wan; Mermagya Dhakal; Christine M Hoeman; Jason A Cascio; Habib Zaghouani
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.